Published in Cancer Weekly, January 3rd, 2006
"Despite the swift escalation in research regarding the use of live bacterial cells for therapeutic purposes, the prophylactic and curative use of probiotic microorganisms still remains a wide and controversial field.
"In addition, the acknowledgement that live bacterial cells can be genetically engineered to synthesize products that have therapeutic potential has generated substantial interest among clinicians and health professionals," wrote scientists in the journal Expert Opinion on Biological Therapy.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.